Among all the resistance-associated genes analyzed, we detected 8 different mutations in 5 genes (rpoB, katG, rrs, inhA, and embB) that confer resistance to first- and second-line anti-TB drugs in 18 of 30 (60.0%) samples. The gene discussed is INHA; the disease is tuberculosis.